LTR Pharma is a Clinical Stage Biopharmaceutical Company
Erectile Dysfunction (ED) is a condition in which you are unable to get or keep an erection firm enough for satisfactory sexual intercourse. ED can be a short-term or long-term problem.
SPONTAN® provides on demand delivery and faster effect. A lower dose provides less systematic exposure and reduced side effects
LTR Pharma is commercialising a ‘First in Class’ rapid treatment for Erectile Dysfunction (ED) SPONTAN® with fast-track US NDA Filing within two years
worldwide expected cases by 2025
minute effectiveness
projected global market value 2024
ED is a serious and common medical problem with significant impacts to both physical and psychological health
ED has been identified as a major factor in relationship breakdown (20%). The worldwide prevalence doubled in the last 30 years and is expected to increase to 322 million in 2025.
The Indian Patent Office has formally granted LTR Pharma Patent No. 605429, titled Formulations and Methods for Treating Erectile Dysfunction. The patent protects defined formulation characteristics of the intranasal technology supporting our SPONTAN® and ROXUS® products, with protection extending to May 2041. The grant represents a further milestone in our
We have appointed prominent Australian entrepreneur, investor and digital-growth specialist Nick Bell as Strategic Adviser to support the commercial growth of our broader men’s health franchise. As Strategic Adviser, Nick will work closely with LTR Pharma’s leadership team to identify and develop commercial opportunities across the Company’s expanding men’s health
LTR Pharma Limited (ASX:LTP) has released its Quarterly Activities Report and Appendix 4C for the three months ending on 30 September 2026. The Quarter saw both U.S. commercial term sheets for ROXUS® converted into definitive agreements, followed shortly after the quarter ended by the first ROXUS prescriptions fulfilled in the
SPONTAN may be prescribed to eligible patients under the TGA’s Special Access Scheme. For more information, please register your details via our online form.